Article thumbnail

Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance

By Evren Yilmaz, Meral Koyuncuoglu, İlknur Bilkay Görken, Emre Okyay, Bahadir Saatli, Emine Cagnur Ulukus and Ugur Saygili
Topics: Original Article
Publisher: Korean Society of Gynecologic Oncology and Colposcopy
OAI identifier: oai:pubmedcentral.nih.gov:3152761
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1997). A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma.
  2. (1999). Analysis of Bcl2, Bax and Survivin genes in uterine cancer.
  3. (1999). Angiogenesis extent and expression of matrix metalloproteinase2 and 9 correlate with upgrading and myometrial invasion in endometrial carcinoma.
  4. Coexpression of survivin, cerbB2, and cyclooxygenase2 (COX2): progno stic value and survival of endometrial cancer patients.
  5. (2002). Correlation of survivin mRNA detec tion with histologic diagnosis in normal endo metrium and endometrial carcinoma. Acta Obstet Gynecol Scand
  6. (1996). Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas. Hum Pathol
  7. Detection of endometrial cancer by determi nation of matrix metalloproteinases in the uterine cavity.
  8. Endometrial cancer.
  9. Endometrial tumor invasiveness is related to me ta llo proteinase 2 and tissue inhibitor of metallopro tei nase 2 expressions.
  10. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle.
  11. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
  12. FIGO staging classifications and clinical practice guide lines in the management of gynecologic cancers: FIGO Committee on Gynecologic Oncology.
  13. (2004). grade and the stage. Gynecol Oncol
  14. (1998). IAPfamily protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res
  15. (1999). Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Anticancer Res
  16. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
  17. (1997). Loss of heterozygo sity in usual and special variant carcinomas of the endo metrium. Hum Pathol
  18. Matrix metalloproteinases 2 and 9, Ecadherin, and beta catenin expression in endometriosis, lowgrade endo met rial carcinoma and nonneoplastic eutopic endo metrium.
  19. (1999). Matrix metalloproteinases in repair. Wound Repair
  20. (1993). Molecular aspects of tumor cell invasion and metastasis. Cancer
  21. (2001). Molecular pathology of endometrial hyper plasia and carcinoma. Hum Pathol
  22. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
  23. (1997). p53 gene mutations are common in uterine serous car cinoma and occur early in their pathogenesis.
  24. Presence of active gelatinases in endometrial car cinoma and correlation of matrix metalloproteinase ex pression with increasing tumor grade and invasion.
  25. Prognostic parameters of endometrial carcinoma.
  26. (2003). Surface epithelialstromal tu mours. In: Tavassoli FA, Devilee P, editors. World Health Or ganization classification of tumours. Pathology and ge netics of the breast and female genital organs.
  27. (1999). Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest
  28. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma.
  29. Survivin expression in endometrial carci noma: a tissue microarray study with correlation with PTEN and STAT3.
  30. (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene
  31. (2001). The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol
  32. (2007). The role of matrix metalloproteinases2, 7 and 9 and betacatenin in high grade endometrial carcinoma. Histopathology
  33. TIMP1, Ecadherin, and betacatenin expression in endo metrial serous carcinoma compared with lowgrade en do metrial endometrioid carcinoma and proliferative endometrium.
  34. (1983). Two pathogenetic types of endometrial car cinoma. Gynecol Oncol